Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methycobalamin in Early Dementia with Vitamin B12 Deficiency
NCT00165711Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2003
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mecobalamin in Dementia and vitamin B12 deficiency, sponsored by Eisai Co., Ltd. Primary endpoint: Mattis Dementia Rating Scale. Started Mar 2003; status: completed.
02
Drugs
mecobalamin
03
Conditions
Dementiavitamin B12 deficiency
Beyond the preview
Go deeper on NCT00165711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165711.